BD Diagnostics has expanded its microbiology portfolio to include instrumentation technologies for lab automation solutions
This follows the group's acquisition of Kiestra Lab Automation, a Netherlands-based company that develops automation solutions for the microbiology lab.
Kiestra's solutions are designed to automate manual and time-consuming tasks to increase productivity, while still relying on the microbiologists' technical expertise to deliver high-quality results.
"Microbiology labs are facing unprecedented challenges - including cost containment pressures and a shortage of qualified staff - while the need for faster delivery of more accurate results is increasing to ensure optimal patient care," said Jamie Condie, Vice President and General Manager of BD Diagnostics - Diagnostic Systems.
"The combination of BD's broad portfolio of microbiology platforms, reagents and supplies with Kiestra's automated instrumentation technologies will enable us to offer a more comprehensive microbiology lab solution to hospitals and laboratories worldwide." Kiestra offers two lines of automated solutions: Total Lab Automation (TLA) and Work Cell Automation (WCA).
Total Lab Automation is designed to significantly increase overall microbiology lab productivity, streamline workflow and shorten the time to results.
The Work Cell solutions offer a modular and scalable approach to automate labs within space and budget constraints.
